PREVALENCE AND OUTCOMES OF MITRAL STENOSIS IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT: FINDINGS FROM THE SOCIETY OF THORACIC SURGEONS/AMERICAN COLLEGE OF CARDIOLOGY (STS/ACC) TRANSCATHETER VALVE THERAPIES (TVT) REGISTRY

Background: The prevalence of mitral stenosis (MS) and its impact on in-hospital and 1 year clinical outcomes in patients undergoing transcatheter aortic valve replacement (TAVR) are unknown. Methods: We included 44,755 adult patients who underwent TAVR (11/1/2011 – 9/30/2015) in the STS/ACC TVT